Skip to main content
SpringerLink
Log in

Pathophysiology and Treatment of Orthostatic Hypotension in Parkinsonian Disorders

  • Movement Disorders (A Videnovich, Section Editor)
  • Published:
Current Treatment Options in Neurology Aims and scope Submit manuscript

Opinion statement

Orthostatic hypotension (OH) is defined as a sustained pathological reduction in blood pressure within 3 min after orthostatic stress such as tilt-table testing or active standing. Non-neurogenic OH is caused by either decreased cardiac output or impaired vasoconstriction without a primary autonomic disorder whereas neurogenic OH results from inadequate release of norepinephrine in the vasomotor sympathetic system. Once non-neurogenic causes of OH such as medications and cardiac problems are ruled out, neurogenic OH can be considered. Neurogenic OH can accompany parkinsonian diseases in different stages and is associated with increased risk of morbidity and mortality. The pathophysiology of neurogenic OH in parkinsonian diseases includes sympathetic neurocirculatory failure and impaired cardiovagal activity. The inadequate release of peripheral norepinephrine upon orthostatic stress is a final pathologic pathway for neurogenic OH and is important for many therapeutic interventions. With mild or early autonomic failure, OH that occurs beyond 3 min of standing (defined as delayed OH) can result in orthostatic intolerance. Supine hypertension and postprandial hypotension are frequent comorbidities and may exacerbate orthostatic hypotension. The non-pharmacologic therapies should be tried initially, followed by pharmacologic treatments. Common medications used in the treatment of OH include fludrocortisone, midodrine, pyridostigmine, and droxidopa. Only midodrine and droxidopa have received FDA approval for the treatment of orthostatic hypotension.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References and Recommended Reading

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Freeman R, Wieling W, Axelrod FB, et al. Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome. Clin Auton Res. 2011;21(2):69–72. This consensus statement provides an up-to-date evidence-based approach to neurogenic orthostatic hypotension.

    Article  PubMed  Google Scholar 

  2. Fedorowski A, Burri P, Melander O. Orthostatic hypotension in genetically related hypertensive and normotensive individuals. J Hypertens. 2009;27(5):976–82.

    Article  CAS  PubMed  Google Scholar 

  3. Goldstein DS, Sharabi Y. Neurogenic orthostatic hypotension: a pathophysiological approach. Circulation. 2009;119(1):139–46.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Isaacson SH, Skettini J. Neurogenic orthostatic hypotension in Parkinson’s disease: evaluation, management, and emerging role of droxidopa. Vasc Health Risk Manag. 2014;10:169–76.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Frewen J, Savva GM, Boyle G, et al. Cognitive performance in orthostatic hypotension: findings from a nationally representative sample. J Am Geriatr Soc. 2014;62(1):117–22.

    Article  PubMed  Google Scholar 

  6. McDonell KE, Shibao CA, Claassen DO. Clinical relevance of orthostatic hypotension in neurodegenerative disease. Curr Neurol Neurosci Rep. 2015;15(12):78.

    Article  PubMed  Google Scholar 

  7. Rutan GH, Hermanson B, Bild DE, et al. Orthostatic hypotension in older adults. The cardiovascular health study. CHS collaborative research group. Hypertension. 1992;19(6 Pt 1):508–19.

    Article  CAS  PubMed  Google Scholar 

  8. Shin C, Abbott RD, Lee H, et al. Prevalence and correlates of orthostatic hypotension in middle-aged men and women in Korea: the Korean Health and Genome Study. J Hum Hypertens. 2004;18(10):717–23.

    Article  CAS  PubMed  Google Scholar 

  9. Low PA. Prevalence of orthostatic hypotension. Clin Auton Res. 2008;18 Suppl 1:8–13.

    Article  PubMed  Google Scholar 

  10. Palma JA, Gomez-Esteban JC, Norcliffe-Kaufmann L, et al. Orthostatic hypotension in Parkinson disease: how much you fall or how low you go? Mov Disord. 2015;30(5):639–45. This recent article shows prevalence of symptomatic orthostatic hypotension in parkinson disease and identifies a hemodynamic target to guide treatment.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Romero-Ortuno R, O’Connell MD, Finucane C, et al. Insights into the clinical management of the syndrome of supine hypertension–orthostatic hypotension (SH-OH): the irish longitudinal study on ageing (TILDA). BMC Geriatr. 2013;13:73.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Gibbons CH, Freeman R. Orthostatic dyspnea: a neglected symptom of orthostatic hypotension. Clin Auton Res. 2005;15(1):40–4.

    Article  PubMed  Google Scholar 

  13. Freeman R. Clinical practice. Neurogenic orthostatic hypotension. N Engl J Med. 2008;358(6):615–24.

    Article  CAS  PubMed  Google Scholar 

  14. Khurana RK. Coat-hanger ache in orthostatic hypotension. Cephalalgia. 2012;32(10):731–7.

    Article  PubMed  Google Scholar 

  15. Yatsuya H, Folsom AR, Alonso A, Gottesman RF, Rose KM, Investigators AS. Postural changes in blood pressure and incidence of ischemic stroke subtypes: the ARIC study. Hypertension. 2011;57(2):167–73.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Milazzo V, Di Stefano C, Milan A, et al. Cardiovascular complications in patients with autonomic failure. Clin Auton Res. 2015;25(3):133–40. This review article provides evidences for cardiovascular, renal and cerebrovascular damages in patients with autonomic failure.

    Article  PubMed  Google Scholar 

  17. Hayakawa T, McGarrigle CA, Coen RF, et al. Orthostatic blood pressure behavior in people with mild cognitive impairment predicts conversion to dementia. J Am Geriatr Soc. 2015;63(9):1868–73.

    Article  PubMed  Google Scholar 

  18. Matinolli M, Korpelainen JT, Korpelainen R, et al. Orthostatic hypotension, balance and falls in Parkinson’s disease. Mov Disord. 2009;24(5):745–51.

    Article  PubMed  Google Scholar 

  19. Nakamura T, Hirayama M, Hara T, et al. Role of cardiac sympathetic nerves in preventing orthostatic hypotension in Parkinson’s disease. Parkinsonism Relat Disord. 2014;20(4):409–14.

    Article  PubMed  Google Scholar 

  20. Sharabi Y, Goldstein DS. Mechanisms of orthostatic hypotension and supine hypertension in Parkinson disease. J Neurol Sci. 2011;310(1-2):123–8. This review article explaines mechanisms and relations between orthostatic hypotension and supine hypertension. It also provides treatment recommendations for both conditions.

    Article  PubMed  Google Scholar 

  21. Gibbons CH, Freeman R. Delayed orthostatic hypotension: a frequent cause of orthostatic intolerance. Neurology. 2006;67(1):28–32.

    Article  PubMed  Google Scholar 

  22. Gibbons CH, Freeman R. Clinical implications of delayed orthostatic hypotension: a 10-year follow-up study. Neurology. 2015;85(16):1362–7. This long-term follow-up study shows clinical importance of delayed orthostatic hypotension as an early sign of autonomic failure.

    Article  PubMed  Google Scholar 

  23. Wieling W, Van Lieshout JJ, Ten Harkel AD. Dynamics of circulatory adjustments to head-up tilt and tilt-back in healthy and sympathetically denervated subjects. Clin Sci (Lond). 1998;94(4):347–52.

    Article  CAS  Google Scholar 

  24. Tipre DN, Goldstein DS. Cardiac and extracardiac sympathetic denervation in Parkinson’s disease with orthostatic hypotension and in pure autonomic failure. J Nucl Med. 2005;46(11):1775–81.

    CAS  PubMed  Google Scholar 

  25. Jansen RW, Lipsitz LA. Postprandial hypotension: epidemiology, pathophysiology, and clinical management. Ann Intern Med. 1995;122(4):286–95.

    Article  CAS  PubMed  Google Scholar 

  26. Trahair LG, Horowitz M, Jones KL. Postprandial hypotension: a systematic review. J Am Med Dir Assoc. 2014;15(6):394–409.

    Article  PubMed  Google Scholar 

  27. Mathias CJ, Holly E, Armstrong E, et al. The influence of food on postural hypotension in three groups with chronic autonomic failure—clinical and therapeutic implications. J Neurol Neurosurg Psychiatry. 1991;54(8):726–30.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Wilcox CS, Aminoff MJ, Slater JD. Sodium homeostasis in patients with autonomic failure. Clin Sci Mol Med. 1977;53(4):321–8.

    CAS  PubMed  Google Scholar 

  29. Biaggioni I. The sympathetic nervous system and blood volume regulation: lessons from autonomic failure patients. Am J Med Sci. 2007;334(1):61–4.

    Article  PubMed  Google Scholar 

  30. Puvi-Rajasingham S, Mathias CJ. Effect of meal size on post-prandial blood pressure and on postural hypotension in primary autonomic failure. Clin Auton Res. 1996;6(2):111–4.

    Article  CAS  PubMed  Google Scholar 

  31. Benarroch EE. The clinical approach to autonomic failure in neurological disorders. Nat Rev Neurol. 2014;10(7):396–407. This review article provides clinical aproach and general treatment guidelines to autonomic failure.

    Article  PubMed  Google Scholar 

  32. Zion AS, De Meersman R, Diamond BE, et al. A home-based resistance-training program using elastic bands for elderly patients with orthostatic hypotension. Clin Auton Res. 2003;13(4):286–92.

    Article  PubMed  Google Scholar 

  33. Smith GD, Mathias CJ. Postural hypotension enhanced by exercise in patients with chronic autonomic failure. QJM. 1995;88(4):251–6.

    CAS  PubMed  Google Scholar 

  34. Low DA, Vichayanrat E, Iodice V, et al. Exercise hemodynamics in Parkinson’s disease and autonomic dysfunction. Parkinsonism Relat Disord. 2014;20(5):549–53.

    Article  PubMed  Google Scholar 

  35. Figueroa JJ, Singer W, Sandroni P, et al. Effects of patient-controlled abdominal compression on standing systolic blood pressure in adults with orthostatic hypotension. Arch Phys Med Rehabil. 2015;96(3):505–10.

    Article  PubMed  PubMed Central  Google Scholar 

  36. Henry R, Rowe J, O’Mahony D. Haemodynamic analysis of efficacy of compression hosiery in elderly fallers with orthostatic hypotension. Lancet. 1999;354(9172):45–6.

    Article  CAS  PubMed  Google Scholar 

  37. Podoleanu C, Maggi R, Brignole M, et al. Lower limb and abdominal compression bandages prevent progressive orthostatic hypotension in elderly persons: a randomized single-blind controlled study. J Am Coll Cardiol. 2006;48(7):1425–32.

    Article  PubMed  Google Scholar 

  38. Taneja I, Moran C, Medow MS, et al. Differential effects of lower body negative pressure and upright tilt on splanchnic blood volume. Am J Physiol Heart Circ Physiol. 2007;292(3):H1420–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  39. Denq JC, Opfer-Gehrking TL, Giuliani M, et al. Efficacy of compression of different capacitance beds in the amelioration of orthostatic hypotension. Clin Auton Res. 1997;7(6):321–6.

    Article  CAS  PubMed  Google Scholar 

  40. Krediet CT, Go-Schon IK, Kim YS, et al. Management of initial orthostatic hypotension: lower body muscle tensing attenuates the transient arterial blood pressure decrease upon standing from squatting. Clin Sci (Lond). 2007;113(10):401–7.

    Article  Google Scholar 

  41. Tutaj M, Marthol H, Berlin D, et al. Effect of physical countermaneuvers on orthostatic hypotension in familial dysautonomia. J Neurol. 2006;253(1):65–72.

    Article  PubMed  Google Scholar 

  42. Krediet CT, de Bruin IG, Ganzeboom KS, et al. Leg crossing, muscle tensing, squatting, and the crash position are effective against vasovagal reactions solely through increases in cardiac output. J Appl Physiol (1985). 2005;99(5):1697–703.

    Article  Google Scholar 

  43. Raj SR, Biaggioni I, Black BK, et al. Sodium paradoxically reduces the gastropressor response in patients with orthostatic hypotension. Hypertension. 2006;48(2):329–34.

    Article  CAS  PubMed  Google Scholar 

  44. Shibao C, Gamboa A, Diedrich A, Biaggioni I. Management of hypertension in the setting of autonomic failure: a pathophysiological approach. Hypertension. 2005;45(4):469–76.

    Article  CAS  PubMed  Google Scholar 

  45. Chobanian AV, Volicer L, Tifft CP, et al. Mineralocorticoid-induced hypertension in patients with orthostatic hypotension. N Engl J Med. 1979;301(2):68–73.

    Article  CAS  PubMed  Google Scholar 

  46. van Lieshout JJ, ten Harkel AD, Wieling W. Fludrocortisone and sleeping in the head-up position limit the postural decrease in cardiac output in autonomic failure. Clin Auton Res. 2000;10(1):35–42.

    Article  PubMed  Google Scholar 

  47. Singer W, Joyner MJ, Sandroni P, et al. Midodrine efficacy in orthostatic hypotension. J Gen Intern Med. 2014;29(11):1440–1.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  48. Izcovich A, Gonzalez Malla C, Manzotti M, et al. Midodrine for orthostatic hypotension and recurrent reflex syncope: a systematic review. Neurology. 2014;83(13):1170–7. This is one of the most recent review articles on midodrine used for orthostatic hypotension. It provides clinical evidence of its use in orthostatic hypotension and its tolerability.

    Article  CAS  PubMed  Google Scholar 

  49. Goldstein DS. L-Dihydroxyphenylserine (L-DOPS): a norepinephrine prodrug. Cardiovasc Drug Rev. 2006;24(3-4):189–203.

    Article  CAS  PubMed  Google Scholar 

  50. Kaufmann H, Freeman R, Biaggioni I, et al. Droxidopa for neurogenic orthostatic hypotension: a randomized, placebo-controlled, phase 3 trial. Neurology. 2014;83(4):328–35. This phase 3 clinical trial demonstrates the efficacy of droxidopa in the treatment of neurogenic orthostatic hypotension.

  51. Biaggioni I, Freeman R, Mathias CJ, et al. Randomized withdrawal study of patients with symptomatic neurogenic orthostatic hypotension responsive to droxidopa. Hypertension. 2015;65(1):101–7. These two phase 3 clinical studies of droxidopa prompted its FDA approval for neurogenic orthostatic hypotension. They show clinical efficacy and tolerability of droxidopa in neurogenic orthostatic hypotension from differenent diseases.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  52. Keating GM. Droxidopa: a review of its use in symptomatic neurogenic orthostatic hypotension. Drugs. 2015;75(2):197–206.

    Article  CAS  PubMed  Google Scholar 

  53. Goldstein DS, Holmes C, Sewell L, et al. Effects of carbidopa and entacapone on the metabolic fate of the norepinephrine prodrug L-DOPS. J Clin Pharmacol. 2011;51(1):66–74.

    Article  CAS  PubMed  Google Scholar 

  54. Mathias CJ. L-dihydroxyphenylserine (Droxidopa) in the treatment of orthostatic hypotension: the European experience. Clin Auton Res. 2008;18 Suppl 1:25–9.

    Article  PubMed  Google Scholar 

  55. Mathias CJ, Senard JM, Braune S, et al. L-threo-dihydroxyphenylserine (L-threo-DOPS; droxidopa) in the management of neurogenic orthostatic hypotension: a multi-national, multi-center, dose-ranging study in multiple system atrophy and pure autonomic failure. Clin Auton Res. 2001;11(4):235–42.

    Article  CAS  PubMed  Google Scholar 

  56. Gales BJ, Gales MA. Pyridostigmine in the treatment of orthostatic intolerance. Ann Pharmacother. 2007;41(2):314–8.

    Article  CAS  PubMed  Google Scholar 

  57. Singer W, Opfer-Gehrking TL, Nickander KK, et al. Acetylcholinesterase inhibition in patients with orthostatic intolerance. J Clin Neurophysiol. 2006;23(5):476–81.

    Article  PubMed  Google Scholar 

  58. Singer W, Opfer-Gehrking TL, McPhee BR, et al. Acetylcholinesterase inhibition: a novel approach in the treatment of neurogenic orthostatic hypotension. J Neurol Neurosurg Psychiatry. 2003;74(9):1294–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  59. Ramirez CE, Okamoto LE, Arnold AC, et al. Efficacy of atomoxetine versus midodrine for the treatment of orthostatic hypotension in autonomic failure. Hypertension. 2014;64(6):1235–40.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  60. Arnold AC, Ramirez CE, Choi L, et al. Combination ergotamine and caffeine improves seated blood pressure and presyncopal symptoms in autonomic failure. Front Physiol. 2014;5:270.

    Article  PubMed  PubMed Central  Google Scholar 

  61. Mathias CJ, Fosbraey P, da Costa DF, et al. The effect of desmopressin on nocturnal polyuria, overnight weight loss, and morning postural hypotension in patients with autonomic failure. Br Med J (Clin Res Ed). 1986;293(6543):353–4.

    Article  CAS  Google Scholar 

  62. Hoeldtke RD, Streeten DH. Treatment of orthostatic hypotension with erythropoietin. N Engl J Med. 1993;329(9):611–5.

    Article  CAS  PubMed  Google Scholar 

  63. Onrot J, Goldberg MR, Biaggioni I, et al. Oral yohimbine in human autonomic failure. Neurology. 1987;37(2):215–20.

    Article  CAS  PubMed  Google Scholar 

  64. Jordan J, Shannon JR, Diedrich A, et al. Water potentiates the pressor effect of ephedra alkaloids. Circulation. 2004;109(15):1823–5.

    Article  CAS  PubMed  Google Scholar 

  65. Onrot J, Goldberg MR, Biaggioni I, et al. Hemodynamic and humoral effects of caffeine in autonomic failure. Therapeutic implications for postprandial hypotension. N Engl J Med. 1985;313(9):549–54.

    Article  CAS  PubMed  Google Scholar 

  66. Freeman R, Young J, Landsberg L, Lipsitz L. The treatment of postprandial hypotension in autonomic failure with 3,4-DL-threo-dihydroxyphenylserine. Neurology. 1996;47(6):1414–20.

    Article  CAS  PubMed  Google Scholar 

  67. Shibao C, Gamboa A, Diedrich A, et al. Acarbose, an alpha-glucosidase inhibitor, attenuates postprandial hypotension in autonomic failure. Hypertension. 2007;50(1):54–61.

    Article  CAS  PubMed  Google Scholar 

  68. Ong AC, Myint PK, Potter JF. Pharmacological treatment of postprandial reductions in blood pressure: a systematic review. J Am Geriatr Soc. 2014;62(4):649–61.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School Center for Autonomic and Peripheral Disorders, 185 Pilgrim Road, Boston, MA, USA

    Dong In Sinn MD & Christopher H. Gibbons MD

Authors
  1. Dong In Sinn MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Christopher H. Gibbons MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Christopher H. Gibbons MD.

Ethics declarations

Conflict of Interest

Dong In Sinn declares no conflict of interest.

Christopher H. Gibbons has served on the Advisory Board of Lundbeck, Inc.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

This article is part of the Topical Collection on Movement Disorders

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

In Sinn, D., Gibbons, C.H. Pathophysiology and Treatment of Orthostatic Hypotension in Parkinsonian Disorders. Curr Treat Options Neurol 18, 28 (2016). https://doi.org/10.1007/s11940-016-0410-9

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s11940-016-0410-9

Keywords

Search

Navigation